Risperidone long-acting injectable
Sponsors
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Conditions
Schizophrenia
Phase 3
Injection Site Tolerability of Multiple Dose Treatment With Long-acting Injectable Risperidone Administered Via Deltoid Muscle in Chronic Schizophrenia Patients.
CompletedNCT00828958
Start: 2006-02-28End: 2006-09-30Updated: 2011-05-18
A Comparison of the Pharmacokinetics and Safety of Long-acting Injectable Risperidone When Administered to Gluteal or Deltoid Intramuscular Injection Sites in Stable Schizophrenia Patients.
CompletedNCT00843687
Start: 2005-09-30End: 2007-03-31Updated: 2011-06-09